CREB3L1 and breast cancer: BT20, HCC1806 and MDA-MB-468 human breast cancer cells were treated with DAC and/or TSA and CREB3L1 mRNA levels were analyzed by qPCR, relative to a GAPDH-specific control (Fig. 2a).